Pricing Log in Create free account

LENZ Therapeutics, Inc. (LENZ) vs NRx Pharmaceuticals, Inc. (NRXP)

LENZ Therapeutics, Inc. and NRx Pharmaceuticals, Inc. are both Biotechnology companies. LENZ Therapeutics, Inc. and NRx Pharmaceuticals, Inc. are of similar size ($98.3M and $94.6M). NRx Pharmaceuticals, Inc. has the higher net margin (−691.8% vs −1,135.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, NRx Pharmaceuticals, Inc. leads on 9 and LENZ Therapeutics, Inc. on 5.

Valuation

Metric LENZ NRXP Biotechnology median
P/E n/m n/m 10.26
P/S 7.73 25.62 9.18
P/B 0.50 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.67 n/m 0.65
EV/Sales (8.06) 19.36 8.98
Earnings yield (147.55%) (23.81%) (34.89%)
Free cash flow yield (133.70%) (23.77%) (24.52%)

Profitability

Metric LENZ NRXP Biotechnology median
Gross margin 85.35% 46.64% 65.16%
Operating margin (1,211.17%) (586.15%) 0.00%
Net margin (1,134.97%) (691.78%) 0.00%
Free cash flow margin (1,033.28%) (609.02%) 0.00%
Return on equity (72.69%) 131.22% (50.12%)
Return on assets (66.72%) (120.41%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LENZ NRXP Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) (21.79%) 43.22% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LENZ NRXP Biotechnology median
Debt to equity 0.00 (2.42) 0.00
Current ratio 11.66 0.86 4.89
Net debt to EBITDA 3.22 0.48 1.01

Dividend

Metric LENZ NRXP Biotechnology median
Dividend yield 0.00% — 0.41%
Payout ratio — — —

Size

Metric LENZ NRXP Biotechnology median
Market cap 94.58m 98.28m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack